Showing results (41-50 of 76) with videos related to
Sort By:
Pageof 8
Life Sciences|December 2, 1985
Neuropeptide Y (NPY) binding sites in rat brain labeled with 125I-Bolton-Hunter NPY: comparative potencies of various polypeptides on brain NPY binding and biological responses in the rat vas deferensR S Chang, V J Lotti, T B Chen, et al.Archives Internationales De Pharmacodynamie Et De Therapie|October 1, 1976
Appetite stimulant activity of 3-carboxy-10,11-dihydrocyproheptadineB V Clineschmidt, H M Hanson, J C McGuffin, et al.Journal of Medicinal Chemistry|June 1, 1977
A comparison of the antiserotonin, antihistamine, and anticholinergic activity of cyproheptadine with analogues having furan nuclei fused to the 10,11-vinylene bridgeD C Remy, A W Raab, K E Rittle, et al.The Journal of Antibiotics|December 1, 1985
Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Fermentation, isolation and biological propertiesM A Goetz, M Lopez, R L Monaghan, et al.The Journal of Antibiotics|July 1, 1988
Novel cholecystokinin antagonists from Aspergillus alliaceus. I. Fermentation, isolation, and biological propertiesM A Goetz, R L Monaghan, R S Chang, et al.The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonistV J Lotti, R G Pendleton, R J Gould, et al.Neuroscience Letters|February 28, 1986
Thyrotropin-releasing hormone receptors in gut tissues resemble pituitary receptorsV J Lotti, R S Chang, D J Cerino, et al.Journal of Medicinal Chemistry|January 1, 1981
Piperazinylquinoxalines with central serotoninmimetic activityW C Lumma, R D Hartman, W S Saari, et al.Journal of Medicinal Chemistry|February 1, 1990
Novel glutamic acid derived cholecystokinin receptor ligandsR M Freidinger, W L Whitter, N P Gould, et al.Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 1, 1984
R-enantiomer of timolol: a potential selective ocular antihypertensive agentN N Share, V J Lotti, P Gautheron, et al.Pageof 8